Ogawa N, Itoh M, Sudo Y, Endo S, Ohashi H, Okugawa T, Furuya R, Hishida A
Third Department of Internal Medicine, Hamamatsu University School of Medicine.
Ryumachi. 1990 Oct;30(5):362-6, 308; discussion 366-8.
A 53-year-old woman was admitted with complaints of edema in the lower legs. The patient had developed polyarthralgia in 1982 and had been treated with D-penicillamine and prednisolone under the diagnosis of rheumatoid arthritis. She then had developed sclerosis of skin as well as dry eyes and dry mouth. In November 1987, bucillamine treatment had started and proteinuria had appeared in February 1988. Her blood showed hypoproteinemia and was positive for anti-Scl-70 antibody test and for anti-SS-A antibody test. The skin biopsy and labial salivary gland biopsy revealed the increased collagen fibers in the subcutaneous tissue and the round cell infiltration around the salivary ducts. We diagnosed her as progressive systemic sclerosis (PSS) with Sjögren's syndrome (SjS) complicated by nephrotic syndrome. Subsequently a renal biopsy was performed. There were the granular deposition of IgG and complements in the glomerular capillary wall and electron dense deposits in the subepithelial region. These findings suggested that she had membranous nephropathy. Since such a renal lesion was rarely observed in PSS and SjS, it was highly probable that bucillamine induced the nephropathy. The bucillamine treatment was discontinued about 2 months after the nephrotic syndrome had developed. However, the nephrotic syndrome has continued for additional 8 months. Thus it is concluded that the renal damage is one of the important side effect caused by bucillamine.
一名53岁女性因小腿水肿入院。该患者于1982年出现多关节痛,在类风湿关节炎诊断下接受青霉胺和泼尼松龙治疗。随后出现皮肤硬化以及干眼症和口干症。1987年11月开始使用布西拉明治疗,1988年2月出现蛋白尿。她的血液检查显示低蛋白血症,抗Scl - 70抗体试验和抗SS - A抗体试验呈阳性。皮肤活检和唇唾液腺活检显示皮下组织胶原纤维增多以及唾液导管周围有圆形细胞浸润。我们诊断她为进行性系统性硬化症(PSS)合并干燥综合征(SjS)并伴有肾病综合征。随后进行了肾活检。在肾小球毛细血管壁有IgG和补体的颗粒状沉积,上皮下区域有电子致密沉积物。这些发现提示她患有膜性肾病。由于在PSS和SjS中很少观察到这种肾脏病变,很可能是布西拉明诱发了肾病。肾病综合征出现后约2个月停用了布西拉明治疗。然而,肾病综合征又持续了8个月。因此得出结论,肾损害是布西拉明引起的重要副作用之一。